Jump to content
RemedySpot.com

RE: Liver Transplant HepatocellularCarcinoma & Medicare Rules

Rate this topic


Recommended Posts

Guest guest
Posted

You are so welcome. I’ve been

through it many times, & I know the MD’s want proof of noncoverage,

so I keep this handy. Commercial payers who follow Medicare guidelines &

will not review on medical necessity alone also deny citing this NCD.

Sher Stirling-Burgin, MHA, RN-BC, CCM

Transplant Financial Coordinator

Liver/Multivisceral Programs

Clarian Transplant

550 N.University Blvd., Rm. 4601

Indpls., IN 46202-5250

Desk:

FAX:

sstirlingburgin@...

http://www.clarian.org/portal/Clarian/transplant

EDST

“Confidential: This e-mail is intended for the use of

the person to whom it is addressed and may contain information that is

privileged and confidential, the disclosure of which is governed by applicable

law. If the reader of this e-mail is not the intended recipient, or the

employee or agent responsible to deliver it to the intended recipient, you are

hereby notified that any dissemination, distribution, or copying of this

information is strictly prohibited. If you have received this message in

error, please notify the sender immediately and delete the related

e-mail.”

From:

TxFinancialCoordinators

[mailto:TxFinancialCoordinators ] On Behalf Of Ingram

Sent: Wednesday, June 09, 2010

1:44 PM

To:

TxFinancialCoordinators

Subject: RE:

Liver Transplant HepatocellularCarcinoma &

Medicare Rules

Thanks so much for this information Sherry...

>>> " Stirling-Burgin, Sherry "

6/9/2010 12:22 PM >>>

Here is the MCR language & link discussing that only HCC is approved,

other malignancies are not:

Content Section

NCD for Adult Liver Transplantation (260.1)

Publication Number

100-3

Manual Section Number

260.1

Version Number

2

Effective Date of this Version

6/19/2006

Implementation Date

6/19/2006

Benefit Category

Inpatient Hospital Services

Note: This may not be an exhaustive list of all applicable Medicare

benefit categories for this item or service.

Indications and Limitations of Coverage

CIM 35-53

A. General

Effective July 15, 1996, adult liver transplantation when performed on

beneficiaries with end stage liver disease other than hepatitis B or

malignancies is covered under Medicare when performed in a facility

which is approved by CMS as meeting institutional coverage criteria.

Effective December 10, 1999, adult liver transplantation when performed

on beneficiaries with end stage liver disease other than malignancies is

covered under Medicare when performed in a facility which is approved by

CMS as meeting institutional coverage criteria.

Effective September 1, 2001, Medicare covers adult liver transplantation

for hepatocellular carcinoma when the following conditions are met:

* The patient is not a candidate for subtotal liver resection;

* The patient's tumor(s) is less than or equal to 5 cm in

diameter;

* There is no macrovascular involvement;

* There is no identifiable extrahepatic spread of tumor to

surrounding lymph nodes, lungs, abdominal organs or bone; and

* The transplant is furnished in a facility which is approved by

CMS as meeting institutional coverage criteria for liver transplants

(See 65 FR 15006).

Adult liver transplantation for other malignancies remains excluded from

coverage. Coverage of adult liver transplantation is effective as of the

date of the facility's approval, but for applications received before

July 13, 1991, can be effective as early as March 8, 1990. (See " Federal

Register " 56 FR 15006 dated April 12, 1991.)

http://www.cms.gov/mcd/viewncd.asp?ncd_id=260.1 & ncd_version=2 & basket=ncd

%3A260%2E1%3A2%3AAdult+Liver+Transplantation

Sher Stirling-Burgin, MHA, RN-BC, CCM

Transplant Financial Coordinator

Liver/Multivisceral Programs

Clarian Transplant

550 N.University Blvd.,

Rm. 4601

Indpls., IN

46202-5250

Desk:

FAX:

sstirlingburgin@...

http://www.clarian.org/portal/Clarian/transplant

EDST

" Confidential: This e-mail is intended for the use of the person to whom

it is addressed and may contain information that is privileged and

confidential, the disclosure of which is governed by applicable law. If

the reader of this e-mail is not the intended recipient, or the employee

or agent responsible to deliver it to the intended recipient, you are

hereby notified that any dissemination, distribution, or copying of this

information is strictly prohibited. If you have received this message

in error, please notify the sender immediately and delete the related

e-mail. "

________________________________

From: TxFinancialCoordinators

[mailto:TxFinancialCoordinators ]

On Behalf Of Gray,

Meredith M

Sent: Wednesday, February 20, 2008 9:03 AM

To: TxFinancialCoordinators

Subject: RE: Liver Transplant Hepatocellular

Carcinoma & Medicare Rules

Joanne,

Here is the link to the CMS page w/ the info you are inquiring about:

http://www.cms.hhs.gov/mcd/viewncd.asp?ncd_id=260.1 & ncd_version=2 & basket

=ncd%3A260%2E1%3A2%3AAdult+Liver+Transplantation

<http://www.cms.hhs.gov/mcd/viewncd.asp?ncd_id=260.1 & ncd_version=2 & baske

t=ncd%3A260%2E1%3A2%3AAdult+Liver+Transplantation>

Meredith Gray

Liver Transplant Financial Coordinator

University of Rochester

Strong Memorial

Hospital

601 Elmwood Avenue Box 602

Rochester, NY 14642

(fax)

(pager)

This message contains information which may be confidential and

privileged. Unless you are the addressee (or authorized to receive for

the addressee), you may not use, copy or disclose to anyone the message

or any information contained in the message (including attachments). If

you have received the message in error, please advise sender by reply

email and delete the message. Thank you!

________________________________

From: TxFinancialCoordinators

[mailto:TxFinancialCoordinators ]

On Behalf Of

Joanne_Cannone@...

Sent: Tuesday, February 19, 2008 8:03 PM

To: TxFinancialCoordinators

Subject: Liver Transplant Hepatocellular

Carcinoma & Medicare Rules

Importance: High

HELP

What are the Medicare regulations regarding liver transplant and

hepatocellular carcinoma

Or where can I find them

THANKS!!

JoAnne Cannone

Lead Patient Financial Liaison

University Transplant Program

1725 W. on St.

Suite 161,

Professional Building

Chicago, IL

60612

Office:

Pager 85-6131

Fax:

************************************************************************

************************************************************************

***********************************

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...